XASXSLX
Market cap728mUSD
Dec 23, Last price
4.92AUD
1D
0.00%
1Q
18.55%
Jan 2017
1,145.57%
Name
Silex Systems Ltd
Chart & Performance
Profile
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 6,868 0.43% | 6,839 62.17% | 4,217 119.13% | |||||||
Cost of revenue | 24,274 | 12,746 | 15,356 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (17,405) | (5,907) | (11,139) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (23,224) | (2,339) | (1,512) | |||||||
Tax Rate | ||||||||||
NOPAT | 5,819 | (3,568) | (9,626) | |||||||
Net income | (22,734) 30.95% | (17,361) 83.44% | (9,464) 36.63% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 2,590 | 114,779 | 38,502 | |||||||
BB yield | -0.21% | -13.57% | -9.35% | |||||||
Debt | ||||||||||
Debt current | 267 | 233 | 200 | |||||||
Long-term debt | 2,096 | 1,078 | 1,565 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 85 | 91 | 71 | |||||||
Net debt | (127,901) | (143,055) | (47,891) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 6,139 | (2,341) | 413 | |||||||
CAPEX | (285) | (94) | (125) | |||||||
Cash from investing activities | 7,559 | (114,396) | (40,064) | |||||||
Cash from financing activities | 2,340 | 114,550 | 38,197 | |||||||
FCF | 8,065 | (6,811) | (10,241) | |||||||
Balance | ||||||||||
Cash | 116,995 | 140,736 | 46,534 | |||||||
Long term investments | 13,269 | 3,630 | 3,122 | |||||||
Excess cash | 129,921 | 144,024 | 49,445 | |||||||
Stockholders' equity | 131,938 | 148,689 | 50,546 | |||||||
Invested Capital | 3,284 | 5,528 | 2,154 | |||||||
ROIC | 132.08% | |||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 236,105 | 214,689 | 196,046 | |||||||
Price | 5.33 35.28% | 3.94 87.62% | 2.10 133.33% | |||||||
Market cap | 1,258,442 48.77% | 845,877 105.46% | 411,696 164.77% | |||||||
EV | 1,130,541 | 702,821 | 363,805 | |||||||
EBITDA | (17,405) | (5,525) | (10,697) | |||||||
EV/EBITDA | ||||||||||
Interest | 41 | 51 | 20 | |||||||
Interest/NOPBT |